• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2在动态免疫环境中的进化

SARS-CoV-2 evolution on a dynamic immune landscape.

作者信息

Raharinirina N Alexia, Gubela Nils, Börnigen Daniela, Smith Maureen Rebecca, Oh Djin-Ye, Budt Matthias, Mache Christin, Schillings Claudia, Fuchs Stephan, Dürrwald Ralf, Wolff Thorsten, Hölzer Martin, Paraskevopoulou Sofia, von Kleist Max

机构信息

Department of Mathematics & Computer Science, Freie Universität Berlin, Berlin, Germany.

International Max-Planck Research School for Biology and Computation (IMPRS-BAC), Max-Planck Institute for Molecular Genetics, Berlin, Germany.

出版信息

Nature. 2025 Mar;639(8053):196-204. doi: 10.1038/s41586-024-08477-8. Epub 2025 Jan 29.

DOI:10.1038/s41586-024-08477-8
PMID:39880955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11882442/
Abstract

Since the onset of the pandemic, many SARS-CoV-2 variants have emerged, exhibiting substantial evolution in the virus' spike protein, the main target of neutralizing antibodies. A plausible hypothesis proposes that the virus evolves to evade antibody-mediated neutralization (vaccine- or infection-induced) to maximize its ability to infect an immunologically experienced population. Because viral infection induces neutralizing antibodies, viral evolution may thus navigate on a dynamic immune landscape that is shaped by local infection history. Here we developed a comprehensive mechanistic model, incorporating deep mutational scanning data, antibody pharmacokinetics and regional genomic surveillance data, to predict the variant-specific relative number of susceptible individuals over time. We show that this quantity precisely matched historical variant dynamics, predicted future variant dynamics and explained global differences in variant dynamics. Our work strongly suggests that the ongoing pandemic continues to shape variant-specific population immunity, which determines a variant's ability to transmit, thus defining variant fitness. The model can be applied to any region by utilizing local genomic surveillance data, allows contextualizing risk assessment of variants and provides information for vaccine design.

摘要

自疫情爆发以来,出现了许多严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体,其病毒刺突蛋白(中和抗体的主要靶点)发生了显著进化。一个合理的假设提出,病毒进化以逃避抗体介导的中和作用(疫苗或感染诱导的),从而最大限度地提高其感染有免疫经验人群的能力。由于病毒感染会诱导中和抗体,因此病毒进化可能会在由局部感染历史塑造的动态免疫环境中发展。在此,我们开发了一个综合的机理模型,纳入深度突变扫描数据、抗体药代动力学和区域基因组监测数据,以预测随时间变化的变体特异性易感个体相对数量。我们表明,这一数量与历史变体动态精确匹配,预测了未来变体动态,并解释了变体动态的全球差异。我们的工作有力地表明,当前的疫情仍在塑造变体特异性群体免疫,群体免疫决定了变体的传播能力,从而定义了变体适应性。通过利用当地基因组监测数据,该模型可应用于任何地区,能够对变体的风险评估进行背景化,并为疫苗设计提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/b3dd1a229690/41586_2024_8477_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/da5922ca1676/41586_2024_8477_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/bcb4c88dcbee/41586_2024_8477_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/ecdda284e53a/41586_2024_8477_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/57a08f3d53b0/41586_2024_8477_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/7e8e64886fb3/41586_2024_8477_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/9f961f2b4b0e/41586_2024_8477_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/ee67acfd973c/41586_2024_8477_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/14349040794a/41586_2024_8477_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/f1a2cc80d812/41586_2024_8477_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/e3d38324e41c/41586_2024_8477_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/4e917874c760/41586_2024_8477_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/274e8bd83164/41586_2024_8477_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/b410c3559a6b/41586_2024_8477_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/8e65a2191d8d/41586_2024_8477_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/b3dd1a229690/41586_2024_8477_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/da5922ca1676/41586_2024_8477_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/bcb4c88dcbee/41586_2024_8477_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/ecdda284e53a/41586_2024_8477_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/57a08f3d53b0/41586_2024_8477_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/7e8e64886fb3/41586_2024_8477_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/9f961f2b4b0e/41586_2024_8477_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/ee67acfd973c/41586_2024_8477_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/14349040794a/41586_2024_8477_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/f1a2cc80d812/41586_2024_8477_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/e3d38324e41c/41586_2024_8477_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/4e917874c760/41586_2024_8477_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/274e8bd83164/41586_2024_8477_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/b410c3559a6b/41586_2024_8477_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/8e65a2191d8d/41586_2024_8477_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1644/11882442/b3dd1a229690/41586_2024_8477_Fig15_ESM.jpg

相似文献

1
SARS-CoV-2 evolution on a dynamic immune landscape.严重急性呼吸综合征冠状病毒2在动态免疫环境中的进化
Nature. 2025 Mar;639(8053):196-204. doi: 10.1038/s41586-024-08477-8. Epub 2025 Jan 29.
2
Deciphering SARS-CoV-2 evolution under antibody immune pressure.解析抗体免疫压力下的新型冠状病毒2演变
Trends Immunol. 2025 Apr;46(4):263-265. doi: 10.1016/j.it.2025.03.002. Epub 2025 Mar 27.
3
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.通过 SARS-CoV-2 刺突蛋白变体逃避中和抗体。
Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.
4
Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.新型冠状病毒XEC变异株N端结构域糖基化突变在免疫逃逸、细胞间融合及刺突蛋白稳定性中的作用
J Virol. 2025 Apr 15;99(4):e0024225. doi: 10.1128/jvi.00242-25. Epub 2025 Mar 26.
5
Spike deep mutational scanning helps predict success of SARS-CoV-2 clades.刺突深度突变扫描有助于预测新冠病毒进化枝的成功情况。
Nature. 2024 Jul;631(8021):617-626. doi: 10.1038/s41586-024-07636-1. Epub 2024 Jul 3.
6
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.SARS-CoV-2 多克隆中和抗体逃逸的高遗传屏障。
Nature. 2021 Dec;600(7889):512-516. doi: 10.1038/s41586-021-04005-0. Epub 2021 Sep 20.
7
AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance.AlphaFold2 对 SARS-CoV-2 刺突奥密克戎 JN.1、KP.2 和 KP.3 变体构象集合的建模和分子动力学模拟:结合能突变分析揭示 ACE2 亲和力的上位驱动因素和抗体耐药性逃逸热点。
Viruses. 2024 Sep 13;16(9):1458. doi: 10.3390/v16091458.
8
SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)中和抗体的特异性在近期感染的婴儿和免疫印记个体之间存在显著差异。
J Virol. 2025 Apr 15;99(4):e0010925. doi: 10.1128/jvi.00109-25. Epub 2025 Mar 25.
9
Mutational Scanning and Binding Free Energy Computations of the SARS-CoV-2 Spike Complexes with Distinct Groups of Neutralizing Antibodies: Energetic Drivers of Convergent Evolution of Binding Affinity and Immune Escape Hotspots.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白复合物与不同组中和抗体的突变扫描及结合自由能计算:结合亲和力趋同进化和免疫逃逸热点的能量驱动因素
Int J Mol Sci. 2025 Feb 11;26(4):1507. doi: 10.3390/ijms26041507.
10
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.SARS-CoV-2 变体 B.1.351 和 B.1.1.7 的抗体抗性。
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.

引用本文的文献

1
Heterogeneous Evolution Among SARS-CoV-2 Genes and Variants of Concern.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因与关注变异株之间的异质性进化
J Med Virol. 2025 Sep;97(9):e70604. doi: 10.1002/jmv.70604.
2
Spike mutations that affect the function and antigenicity of recent KP.3.1.1-like SARS-CoV-2 variants.影响近期类似KP.3.1.1的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体功能和抗原性的刺突突变。
bioRxiv. 2025 Aug 19:2025.08.18.671001. doi: 10.1101/2025.08.18.671001.
3
Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1.

本文引用的文献

1
Participatory, Virologic, and Wastewater Surveillance Data to Assess Underestimation of COVID-19 Incidence, Germany, 2020-2024.参与式、病毒学和废水监测数据评估 2020-2024 年德国 COVID-19 发病率的低估。
Emerg Infect Dis. 2024 Sep;30(9):1939-1943. doi: 10.3201/eid3009.240640.
2
Wastewater-based surveillance models for COVID-19: A focused review on spatio-temporal models.用于新冠病毒的基于废水的监测模型:对时空模型的重点综述
Heliyon. 2023 Nov 8;9(11):e21734. doi: 10.1016/j.heliyon.2023.e21734. eCollection 2023 Nov.
3
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.
阿米替林能有效中和包括D614G、奥密克戎BA.5和奥密克戎XBB.1在内的不同严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体。
Front Microbiol. 2025 Aug 4;16:1631947. doi: 10.3389/fmicb.2025.1631947. eCollection 2025.
4
Atypical Influenza A(H3N2) Activity Patterns in Germany, 2021-2023, and Characterization of Newly Emerged Virus Clades.2021 - 2023年德国非典型甲型(H3N2)流感活动模式及新出现病毒谱系的特征分析
J Med Virol. 2025 Aug;97(8):e70530. doi: 10.1002/jmv.70530.
5
Integrated Analysis of the 2022 SARS-CoV-2 Omicron Lineage Replacement Dynamics in Connecticut, US.美国康涅狄格州2022年新冠病毒奥密克戎谱系替代动态的综合分析
Viruses. 2025 Jul 21;17(7):1020. doi: 10.3390/v17071020.
6
Mechanistic Exploration of Yiqi Zengmian in Regulating the Microenvironment as an Immunopotentiator with the Beijing Bio-Institute of Biological Products Coronavirus Vaccine Based on Transcriptomics and Integrated Serum Pharmacochemistry.基于转录组学和血清药物化学整合技术,以北京生物制品研究所新冠病毒疫苗为基础,对益气增免作为免疫增强剂调节微环境的作用机制进行探索
Pharmaceuticals (Basel). 2025 May 27;18(6):802. doi: 10.3390/ph18060802.
7
ALBACOVIDIOL Study: Effect of Calcifediol Treatment on Mortality in Patients Hospitalized for COVID-19: A Retrospective Analysis.ALBACOVIDIOL研究:骨化二醇治疗对COVID-19住院患者死亡率的影响:一项回顾性分析。
Nutrients. 2025 Jun 10;17(12):1968. doi: 10.3390/nu17121968.
8
Demultiplexing and barcode-specific adaptive sampling for nanopore direct RNA sequencing.用于纳米孔直接RNA测序的解复用和条形码特异性自适应采样
Nat Commun. 2025 Apr 21;16(1):3742. doi: 10.1038/s41467-025-59102-9.
9
Spike Protein-Fibrinogen Interaction: A Novel Immune Evasion Strategy of SARS-CoV-2?刺突蛋白与纤维蛋白原的相互作用:新型冠状病毒的一种免疫逃逸策略?
ACS Pharmacol Transl Sci. 2025 Mar 19;8(4):1182-1184. doi: 10.1021/acsptsci.5c00122. eCollection 2025 Apr 11.
10
VirusWarn: A mutation-based early warning system to prioritize concerning SARS-CoV-2 and influenza virus variants from sequencing data.病毒预警:一种基于突变的早期预警系统,用于根据测序数据对值得关注的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和流感病毒变体进行优先级排序。
Comput Struct Biotechnol J. 2025 Mar 12;27:1081-1088. doi: 10.1016/j.csbj.2025.03.010. eCollection 2025.
多次感染奥密克戎会颠覆原始 SARS-CoV-2 免疫印记。
Nature. 2024 Jan;625(7993):148-156. doi: 10.1038/s41586-023-06753-7. Epub 2023 Nov 22.
4
Population immunity predicts evolutionary trajectories of SARS-CoV-2.人群免疫力预测了 SARS-CoV-2 的进化轨迹。
Cell. 2023 Nov 9;186(23):5151-5164.e13. doi: 10.1016/j.cell.2023.09.022. Epub 2023 Oct 23.
5
Learning from prepandemic data to forecast viral escape.从大流行前的数据中学习以预测病毒逃逸。
Nature. 2023 Oct;622(7984):818-825. doi: 10.1038/s41586-023-06617-0. Epub 2023 Oct 11.
6
Towards the development of a SARS-CoV-2 variant risk assessment tool: expert consultation on the assessment of scientific evidence on emerging variants.迈向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株风险评估工具的开发:关于新兴变异株科学证据评估的专家咨询
Lancet Microbe. 2023 Oct;4(10):e830-e836. doi: 10.1016/S2666-5247(23)00179-9. Epub 2023 Aug 25.
7
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant.奥密克戎亚变体导致 BQ.1.1 变体出现的趋同进化。
Nat Commun. 2023 May 11;14(1):2671. doi: 10.1038/s41467-023-38188-z.
8
SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study.法国关注变异株、个体因素和感染情况的 SARS-CoV-2 潜伏期:ComCor 研究的病例系列分析。
Lancet Microbe. 2023 Jun;4(6):e409-e417. doi: 10.1016/S2666-5247(23)00005-8. Epub 2023 Apr 18.
9
The evolution of SARS-CoV-2.严重急性呼吸综合征冠状病毒2的进化
Nat Rev Microbiol. 2023 Jun;21(6):361-379. doi: 10.1038/s41579-023-00878-2. Epub 2023 Apr 5.
10
Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain.抗原呈递动力学塑造了对原始毒株多次接种后像 SARS-CoV-2 奥密克戎这样的变体的抗体反应。
Cell Rep. 2023 Apr 25;42(4):112256. doi: 10.1016/j.celrep.2023.112256. Epub 2023 Mar 6.